Clinical Trial Update: Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

View source ↗

Summary

A pediatric trial evaluating the safety of vitamin D receptor activators in chronic kidney disease stage 5 patients on peritoneal dialysis was terminated, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Secondary Hyperparathyroidism, End-Stage Renal Disease | Status: TERMINATED | Results posted: 2013-08-13